![](/img/cover-not-exists.png)
When Evaluating Parameter Uncertainty Is Not Enough: The Case of Dasatinib and Nilotinib for Imatinib-Resistant Chronic Myeloid Leukemia
Shelby D. ReedVolume:
14
Year:
2011
Language:
english
DOI:
10.1016/j.jval.2011.10.001
File:
PDF, 220 KB
english, 2011